Holobiome has a total of 20 patents globally, out of which 2 have been granted. Of these 20 patents, more than 85% patents are active. The United States of America is where Holobiome has filed the maximum number of patents, followed by Australia, Canada and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Holobiome.
Holobiome was founded in 2015. Holobiome owns and operates a therapeutic company dedicated to addressing disorders affecting the enteric and central nervous systems.
Do read about some of the most popular patents of Holobiome which have been covered by us in this article and also you can find Holobiome patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Holobiome patent portfolio.
How many patents does Holobiome have?
Holobiome has a total of 20 patents globally. These patents belong to 3 unique patent families. Out of 20 patents, 17 patents are active.
How Many Patents did Holobiome File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Holobiome Applications Filed | Holobiome Patents Granted |
| 2023 | 1 | 1 |
| 2021 | 1 | – |
| 2020 | 10 | – |
| 2019 | 1 | – |
| 2017 | 7 | – |
| 2013 | – | 1 |
How many Holobiome patents are Alive/Dead?
Worldwide Patents
How Many Patents did Holobiome File in Different Countries?
Countries in which Holobiome Filed Patents
| Country | Patent |
| United States Of America | 4 |
| Australia | 3 |
| Canada | 3 |
| Europe | 3 |
| Japan | 2 |
| China | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centers of Holobiome Patents Located?
The Research Centers of Holobiome Patents is the United States of America.
Best Holobiome Patents
WO2017160711A1 is the most popular patent in the Holobiome portfolio. It has received 229 citations so far from companies like Evelo Biosciences, 4D Pharma Research Limited, Seres Therapeutics.
Below is the list of most cited patents of Holobiome:
| Publication Number | Citation Count |
| WO2017160711A1 | 65 |
| WO2020160183A1 | 8 |
| CN109715177A | 7 |
| CA3016911A1 | 5 |
| US20220096574A1 | 3 |
| CA3126424A1 | 3 |
| US11116804B2 | 2 |
| US20220040242A1 | 1 |
| EP3429604A1 | 1 |
What Percentage of Holobiome US Patent Applications Were Granted?
Holobiome (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Holobiome patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Holobiome?
| Law Firm | Total Applications | Success Rate |
| Cooley Llp | 2 | 100% |
| Mark J Fitzgerald | 2 | 0% |
List of Holobiome patents
| Holobiome Patents | Title |
| US11116804B2 | Modulation Of The Gut Microbiome To Treat Mental Disorders Or Diseases Of The Central Nervous System |
| US20220370518A1 | Therapeutic Compositions And Methods Of Using Serotonin Modulating Microbiome-Based Interventions To Treat Serotonin-Related Diseases Or Disorders |
| US20220096574A1 | Methods And Compositions For Treating And Preventing Central Nervous System Disorders And Other Conditions Caused By Gut Microbial Dysbiosis |
| US20220040242A1 | Modulation Of The Gut Microbiome To Treat Mental Disorders Or Diseases Of The Central Nervous System |
| EP3989992A4 | Therapeutic Compositions And Methods Of Using Serotonin Modulating Microbiome-Based Interventions To Treat Serotonin-Related Diseases Or Disorders |
| EP3906037A4 | Methods And Compositions For Treating And Preventing Cns Disorders And Other Conditions Caused By Gut Microbial Dysbiosis |
| EP3429604A1 | Modulation Of The Gut Microbiome To Treat Mental Disorders Or Diseases Of The Central Nervous System |
| CN109715177A | Modulation Of The Gut Microbiome To Treat Mental Disorders Or Diseases Of The Central Nervous System |
| AU2020308897A1 | Therapeutic Compositions And Methods Of Using Serotonin Modulating Microbiome-Based Interventions To Treat Serotonin-Related Diseases Or Disorders |
| AU2020215036A1 | Methods And Compositions For Treating And Preventing Cns Disorders And Other Conditions Caused By Gut Microbial Dysbiosis |
| CA3144072A1 | Therapeutic Compositions And Methods Of Using Serotonin Modulating Microbiome-Based Interventions To Treat Serotonin-Related Diseases Or Disorders |
| CA3126424A1 | Methods And Compositions For Treating And Preventing Cns Disorders And Other Conditions Caused By Gut Microbial Dysbiosis |
| AU2017234120A1 | Modulation Of The Gut Microbiome To Treat Mental Disorders Or Diseases Of The Central Nervous System |
| CA3016911A1 | Modulation Of The Gut Microbiome To Treat Mental Disorders Or Diseases Of The Central Nervous System |
| JP7216998B2 | Modification Of The Gut Microbiome To Treat Central Nervous System Psychiatric Disorders Or Diseases |
| JP2023038274A5 | Modifying The Gut Microbiome To Treat Central Nervous System Psychiatric Disorders Or Diseases |
| HK40003260A | Modulation Of The Gut Microbiome To Treat Mental Disorders Or Diseases Of The Central Nervous System |
| WO2020264390A3 | Therapeutic Compositions And Methods Of Using Serotonin Modulating Microbiome-Based Interventions To Treat Serotonin-Related Diseases Or Disorders |
| WO2020160183A1 | Methods And Compositions For Treating And Preventing Cns Disorders And Other Conditions Caused By Gut Microbial Dysbiosis |
| WO2017160711A1 | Modulation Of The Gut Microbiome To Treat Mental Disorders Or Diseases Of The Central Nervous System |
What are Holobiome key innovation segments?
What Technologies are Covered by Holobiome?
The chart below distributes patents filed by Holobiome